Heidelberg, February 1, 2023
Precisis receives TOP 100 seal
Successful participation in innovation competition / Ranga Yogeshwar congratulates the company in June.
Read morePress
Good prospects for the future.
You can read about our progress and milestones, about our expansions and our experts, about our engagement and exchanges, in brief: about everything that motivates us.
Press Releases
![]()
![]()
Heidelberg, September 23, 2022
EASEE® – World's first minimally invasive brain pacemaker for the treatment of epilepsy receives CE-certification and is available immediately
After seven years of development work, Precisis GmbH, headquartered in Heidelberg, has received the CE certification for its minimally invasive brain pacemaker EASEE®.
Read more![]()
Heidelberg, April 29, 2022
Clinical Studies Demonstrate that Patients with Focal Epilepsies Benefit from the Technologically Innovative Therapy EASEE®
Prof. Andreas Schulze-Bonhage, MD, Head of the Epilepsy Center at the University Hospital Freiburg, who is responsible for the multi-center study on the efficacy of EASEE®, present […]
Read more![]()
Heidelberg, February 21, 2022
Minimally Invasive Epilepsy Treatment EASEE® Receives FDA Breakthrough Device Designation
Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE® brain stimulator. FDA’s breakthrough dev […]
Read more![]()
Heidelberg, October 21, 2021
Precisis concludes funding round of €20 million for its bioelectric brain stimulation system
Today, Precisis GmbH, based in Heidelberg, announced that it has successfully concluded a funding round of €20 million with Cochlear Limited. Precisis is a medical technology compa […]
Read more
Thank you for your interest
We will send you a confirmation email to verify your email address. Please open that email and follow the link it contains to complete registration for the newsletter
News about epilepsy directly to your mailbox
We would be happy to inform you regularly